Pimozide
Back to searchMolecule Structure
Scientific Name
Pimozide
Description of the Drug
Pimozide is an antipsychotic used to manage debilitating motor and phonic tics in patients with Tourette’s Disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01100
http://www.drugbank.ca/drugs/DB01100
Brand Name(s)
Orap, Pimozide
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Par Pharmaceutical Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2096905 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL41584 | |
PharmGKB | PA450965 | |
Human Metabolome Database | HMDB0015232 | |
DrugBank | DB01100 | |
PubChem: Thomson Pharma | 14882544 | |
PubChem | 16362 | |
Mcule | MCULE-9624510567 | |
LINCS | LSM-2001 | |
Nikkaji | J3.698F | |
PDBe | 1II | |
BindingDB | 50334150 | |
EPA CompTox Dashboard | DTXSID8023474 | |
DrugCentral | 2172 | |
Brenda | 220067 | 72164 |
ChemicalBook | CB7290660 | |
Guide to Pharmacology | 90 | |
rxnorm | PIMOZIDE | ORAP |
PubChem: Drugs of the Future | 12013418 | |
KEGG Ligand | C07566 | |
ChEBI | 8212 | |
ZINC | ZINC000004175630 |